HOSA PHARMACOLOGY LATEST EXAM 400 QUESTIONS
AND VERIFIED ANSWERS WITH RATIONALE NEW UPDATE
2026-2027 ALREADY A+ GRADE
This document is a comprehensive, original 400-question practice examination
specifically designed for students preparing for the HOSA Pharmacology
competitive event, with each question presented in a clean, standardized
format where the question number and stem appear on the same line,
followed by four multiple-choice options (A, B, C, and D), the correct answer,
and a detailed clinical rationale that explains the underlying pharmacology,
mechanism of action, adverse effects, and clinical reasoning for each answer
choice. The questions comprehensively cover all major topics tested on the
official HOSA Pharmacology exam, including pharmacokinetics (ADME),
pharmacodynamics, drug classifications and mechanisms, autonomic and
cardiovascular pharmacology, central nervous system drugs, antimicrobial
agents, chemotherapy, immunomodulators, and endocrine medications, while
also incorporating high-yield clinical scenarios involving drug interactions,
adverse effect monitoring, contraindications, and therapeutic decision-
making. This document contains no subtitles, headings, star tags, or
markdown formatting, making it ready for direct copying and pasting into a
Microsoft Word document for convenient printing, digital review, or self-
assessment purposes.
1. A patient is prescribed a medication that blocks the reuptake of serotonin and
norepinephrine. This drug primarily affects which process?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Answer: A
Rationale: Reuptake inhibition occurs at the neuronal synapse during the
absorption phase of pharmacokinetics, as the drug enters the systemic circulation
and crosses the blood-brain barrier to act on neurotransmitters. Distribution,
metabolism, and excretion occur after the drug has already been absorbed.
,2. A drug has a half-life of 4 hours. How much of the drug will remain in the body
after 16 hours if the initial dose was 200 mg?
A) 100 mg
B) 50 mg
C) 25 mg
D) 12.5 mg
Answer: D
Rationale: After each half-life, the drug concentration halves. After 4 hours (1 half-
life) = 100 mg, 8 hours (2) = 50 mg, 12 hours (3) = 25 mg, and 16 hours (4) = 12.5
mg. This demonstrates first-order elimination kinetics.
3. Which route of administration results in the fastest onset of action for a lipid-
soluble drug?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
Answer: C
Rationale: Intravenous administration delivers the drug directly into the
bloodstream, bypassing absorption barriers. This provides 100% bioavailability
and the fastest onset, especially for lipid-soluble drugs that readily cross cell
membranes.
4. A patient with liver cirrhosis is prescribed morphine. What pharmacokinetic
change is most concerning?
A) Increased absorption
B) Decreased first-pass metabolism
C) Increased renal excretion
D) Decreased protein binding
Answer: B
Rationale: Liver cirrhosis reduces hepatic blood flow and enzyme activity,
significantly decreasing first-pass metabolism. This leads to higher systemic
bioavailability of morphine, increasing the risk of toxicity and respiratory
depression.
5. The therapeutic index of a drug is 2. This indicates that the drug:
A) Has a wide margin of safety
B) Has a narrow margin of safety
C) Is completely safe at all doses
,D) Has no side effects
Answer: B
Rationale: The therapeutic index (TI) is the ratio of the lethal dose (LD50) to the
effective dose (ED50). A TI of 2 is very narrow, meaning the toxic dose is only
twice the effective dose, requiring careful monitoring to avoid adverse effects.
6. Which receptor type is targeted by beta-blockers like propranolol?
A) G-protein coupled receptors
B) Ligand-gated ion channels
C) Intracellular receptors
D) Enzyme-linked receptors
Answer: A
Rationale: Beta-adrenergic receptors are G-protein coupled receptors (GPCRs).
Beta-blockers act as antagonists at these receptors, preventing catecholamines like
norepinephrine from activating the G-protein signaling cascade.
7. A patient taking warfarin is started on amiodarone. What drug interaction is
most likely?
A) Decreased warfarin effect
B) Increased warfarin effect
C) No change in warfarin effect
D) Increased warfarin metabolism
Answer: B
Rationale: Amiodarone inhibits CYP2C9 and CYP1A2, the enzymes responsible
for warfarin metabolism. This decreases warfarin clearance, leading to increased
INR and a significantly elevated risk of bleeding.
8. Which lab value would indicate nephrotoxicity from an aminoglycoside
antibiotic?
A) Elevated BUN and creatinine
B) Elevated liver enzymes
C) Decreased platelet count
D) Increased white blood cell count
Answer: A
Rationale: Aminoglycosides accumulate in the renal proximal tubule cells, causing
acute tubular necrosis. Elevated blood urea nitrogen (BUN) and serum creatinine
are hallmark indicators of decreased glomerular filtration and kidney damage.
9. A patient experiences muscle pain and dark urine after starting a statin. This is
most likely due to:
, A) Hepatotoxicity
B) Rhabdomyolysis
C) Nephrotic syndrome
D) Hemolytic anemia
Answer: B
Rationale: Statins can cause myopathy and rhabdomyolysis, where skeletal muscle
breaks down releasing myoglobin. Myoglobinuria causes dark urine and can lead
to acute kidney injury if not promptly recognized and treated.
10. Which drug class is contraindicated in a patient with a history of anaphylactic
reaction to sulfonamides?
A) Penicillins
B) Cephalosporins
C) Thiazide diuretics
D) Macrolides
Answer: C
Rationale: Thiazide diuretics (e.g., hydrochlorothiazide) contain a sulfonamide
group and share cross-sensitivity with sulfa antibiotics. Patients with a severe sulfa
allergy should avoid thiazides due to risk of cross-reaction.
11. A patient on digoxin presents with nausea, vomiting, and yellow halos around
lights. What electrolyte imbalance is most likely contributing?
A) Hyperkalemia
B) Hypokalemia
C) Hypermagnesemia
D) Hypercalcemia
Answer: B
Rationale: Hypokalemia potentiates digoxin toxicity by increasing the binding of
digoxin to cardiac sodium-potassium ATPase pumps. This leads to classic signs of
digoxin toxicity including GI symptoms (nausea, vomiting) and visual disturbances
(yellow halos).
12. The mechanism of action of ACE inhibitors like lisinopril involves:
A) Blocking angiotensin II receptors
B) Inhibiting the conversion of angiotensin I to angiotensin II
C) Increasing aldosterone secretion
D) Blocking beta-1 receptors
Answer: B
Rationale: ACE inhibitors block the angiotensin-converting enzyme, which is
responsible for converting the inactive angiotensin I into the potent vasoconstrictor
AND VERIFIED ANSWERS WITH RATIONALE NEW UPDATE
2026-2027 ALREADY A+ GRADE
This document is a comprehensive, original 400-question practice examination
specifically designed for students preparing for the HOSA Pharmacology
competitive event, with each question presented in a clean, standardized
format where the question number and stem appear on the same line,
followed by four multiple-choice options (A, B, C, and D), the correct answer,
and a detailed clinical rationale that explains the underlying pharmacology,
mechanism of action, adverse effects, and clinical reasoning for each answer
choice. The questions comprehensively cover all major topics tested on the
official HOSA Pharmacology exam, including pharmacokinetics (ADME),
pharmacodynamics, drug classifications and mechanisms, autonomic and
cardiovascular pharmacology, central nervous system drugs, antimicrobial
agents, chemotherapy, immunomodulators, and endocrine medications, while
also incorporating high-yield clinical scenarios involving drug interactions,
adverse effect monitoring, contraindications, and therapeutic decision-
making. This document contains no subtitles, headings, star tags, or
markdown formatting, making it ready for direct copying and pasting into a
Microsoft Word document for convenient printing, digital review, or self-
assessment purposes.
1. A patient is prescribed a medication that blocks the reuptake of serotonin and
norepinephrine. This drug primarily affects which process?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Answer: A
Rationale: Reuptake inhibition occurs at the neuronal synapse during the
absorption phase of pharmacokinetics, as the drug enters the systemic circulation
and crosses the blood-brain barrier to act on neurotransmitters. Distribution,
metabolism, and excretion occur after the drug has already been absorbed.
,2. A drug has a half-life of 4 hours. How much of the drug will remain in the body
after 16 hours if the initial dose was 200 mg?
A) 100 mg
B) 50 mg
C) 25 mg
D) 12.5 mg
Answer: D
Rationale: After each half-life, the drug concentration halves. After 4 hours (1 half-
life) = 100 mg, 8 hours (2) = 50 mg, 12 hours (3) = 25 mg, and 16 hours (4) = 12.5
mg. This demonstrates first-order elimination kinetics.
3. Which route of administration results in the fastest onset of action for a lipid-
soluble drug?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
Answer: C
Rationale: Intravenous administration delivers the drug directly into the
bloodstream, bypassing absorption barriers. This provides 100% bioavailability
and the fastest onset, especially for lipid-soluble drugs that readily cross cell
membranes.
4. A patient with liver cirrhosis is prescribed morphine. What pharmacokinetic
change is most concerning?
A) Increased absorption
B) Decreased first-pass metabolism
C) Increased renal excretion
D) Decreased protein binding
Answer: B
Rationale: Liver cirrhosis reduces hepatic blood flow and enzyme activity,
significantly decreasing first-pass metabolism. This leads to higher systemic
bioavailability of morphine, increasing the risk of toxicity and respiratory
depression.
5. The therapeutic index of a drug is 2. This indicates that the drug:
A) Has a wide margin of safety
B) Has a narrow margin of safety
C) Is completely safe at all doses
,D) Has no side effects
Answer: B
Rationale: The therapeutic index (TI) is the ratio of the lethal dose (LD50) to the
effective dose (ED50). A TI of 2 is very narrow, meaning the toxic dose is only
twice the effective dose, requiring careful monitoring to avoid adverse effects.
6. Which receptor type is targeted by beta-blockers like propranolol?
A) G-protein coupled receptors
B) Ligand-gated ion channels
C) Intracellular receptors
D) Enzyme-linked receptors
Answer: A
Rationale: Beta-adrenergic receptors are G-protein coupled receptors (GPCRs).
Beta-blockers act as antagonists at these receptors, preventing catecholamines like
norepinephrine from activating the G-protein signaling cascade.
7. A patient taking warfarin is started on amiodarone. What drug interaction is
most likely?
A) Decreased warfarin effect
B) Increased warfarin effect
C) No change in warfarin effect
D) Increased warfarin metabolism
Answer: B
Rationale: Amiodarone inhibits CYP2C9 and CYP1A2, the enzymes responsible
for warfarin metabolism. This decreases warfarin clearance, leading to increased
INR and a significantly elevated risk of bleeding.
8. Which lab value would indicate nephrotoxicity from an aminoglycoside
antibiotic?
A) Elevated BUN and creatinine
B) Elevated liver enzymes
C) Decreased platelet count
D) Increased white blood cell count
Answer: A
Rationale: Aminoglycosides accumulate in the renal proximal tubule cells, causing
acute tubular necrosis. Elevated blood urea nitrogen (BUN) and serum creatinine
are hallmark indicators of decreased glomerular filtration and kidney damage.
9. A patient experiences muscle pain and dark urine after starting a statin. This is
most likely due to:
, A) Hepatotoxicity
B) Rhabdomyolysis
C) Nephrotic syndrome
D) Hemolytic anemia
Answer: B
Rationale: Statins can cause myopathy and rhabdomyolysis, where skeletal muscle
breaks down releasing myoglobin. Myoglobinuria causes dark urine and can lead
to acute kidney injury if not promptly recognized and treated.
10. Which drug class is contraindicated in a patient with a history of anaphylactic
reaction to sulfonamides?
A) Penicillins
B) Cephalosporins
C) Thiazide diuretics
D) Macrolides
Answer: C
Rationale: Thiazide diuretics (e.g., hydrochlorothiazide) contain a sulfonamide
group and share cross-sensitivity with sulfa antibiotics. Patients with a severe sulfa
allergy should avoid thiazides due to risk of cross-reaction.
11. A patient on digoxin presents with nausea, vomiting, and yellow halos around
lights. What electrolyte imbalance is most likely contributing?
A) Hyperkalemia
B) Hypokalemia
C) Hypermagnesemia
D) Hypercalcemia
Answer: B
Rationale: Hypokalemia potentiates digoxin toxicity by increasing the binding of
digoxin to cardiac sodium-potassium ATPase pumps. This leads to classic signs of
digoxin toxicity including GI symptoms (nausea, vomiting) and visual disturbances
(yellow halos).
12. The mechanism of action of ACE inhibitors like lisinopril involves:
A) Blocking angiotensin II receptors
B) Inhibiting the conversion of angiotensin I to angiotensin II
C) Increasing aldosterone secretion
D) Blocking beta-1 receptors
Answer: B
Rationale: ACE inhibitors block the angiotensin-converting enzyme, which is
responsible for converting the inactive angiotensin I into the potent vasoconstrictor
